瑞德西韋一開始被說成神藥，病人用了以後24小時就退燒，48小時就痊癒！藥名更被有些人音譯成“人民的希望”！而且製藥廠Gilead非常大度地表示不介意成本全力提供給中國人救命用，感動了一大批人，而且又有報道，特朗普親自批准公開分子式給中國免費使用到4月27號！現在看來，可能我們上當了，當了人體小白鼠！
下面是美軍傳染病研究院所在縣的報紙The Frederick news-post 2019-8-7的一篇報道，提到了瑞德西韋和研究院的關係，以及實驗室被CDC下令關閉後，縣衛生局接到研究院通知可能會在當地造成安全問題的溝通情況。英文原文附後。
-xxxxxxxxxxxxxxxxxxxxxxxx
USAMRIID停工對Fort Detrick研究的影響尚不清楚（USAMRIID即美國陸軍傳染的醫學研究所，所在地是Fort Detrick, 它又屬於Frederick縣）
作者: 希瑟·蒙吉利奧[email protected] 2019年8月7日7
疾病控制與預防中心決定關閉Fort Detrick的軍事實驗室可能會影響正在進行的研究。
在CDC發出停止和終止通知時，美國陸軍傳染病醫學研究所正在進行一項為期多年的項目，以開發針對四種致命病毒的基於抗體的療法。
根據新聞稿，該項目由蒙特菲奧雷醫學中心下屬的阿爾伯特·愛因斯坦醫學院領導，並在四月份獲得了2200萬美元的資助。 Mapp Biopharmaceutical(生物醫藥) Inc.，德克薩斯大學奧斯汀分校和Adimab LLC也是合作伙伴。
據先前的《新聞郵報》報道，軍事實驗室自7月收到6月份檢查後發送的CDC信函以來一直處於離線狀態。 該實驗室在“聯邦精選代理計劃”中的註冊也被暫停。
目前尚不清楚7月的研究終中止將如何影響該項目。 USAMRIID正在努力滿足CDC和陸軍設定的基準，以便它可以再次開始研究，但是尚不清楚需要多長時間。
這個為期五年的項目的目標是為克里米亞-剛果出血熱病毒，安第斯病毒，辛諾布爾病毒和普馬拉病毒創建治療方案，這些疫苗沒有任何經過批准的疫苗或治療方法。 克里米亞-剛果出血熱病毒屬於美國衛生與公共服務部的精選製劑和毒素清單。
一位女發言人在一封電子郵件中說，阿爾伯特·愛因斯坦醫學院沒有人可以回答有關USAMRIID研究被關閉的問題。
阿爾伯特·愛因斯坦（Albert Einstein）項目只是USAMRIID正在進行的眾多項目之一。
3月，USAMRIID宣佈，美國食品藥品管理局（FDA）提供了一項協議，該協議將允許一種動物模型幫助開發用於治療埃博拉病毒的叫Remdesivire，瑞德西偉。
Remdesivir（瑞德西偉）由Gilead Sciences Inc.在USAMRIID和CDC的協助下開發。
2017年9月宣佈，USAMRIID也是Tasso Inc.，Ceres Nanosciences和George Mason University與Tasso Inc.，Ceres Nanosciences和George Mason University共同投資1170萬美元的項目的一部分，該項目將創建一個通用的傳染病暴發監測平臺。
截至星期三下午6點，我們發出的對吉利德，塔索和塞雷斯發表評論的請求仍沒有得到任何回覆。 USAMRIID的發言人則仍在對回答我們的問詢進行準備工作
縣裡是何時知道的
弗雷德裡克（Frederick）縣衛生局醫療保健聯繫與準備部主任蘭德爾·卡爾珀（Randall Culpepper）表示，在7月中旬發出停止和停工通知後，就通知了弗雷德裡克縣衛生局。 該部門將在本週再次與USAMRIID官員會面。
他說，只要有情況發生或有潛在的公共衛生威脅，USAMRIID就會通知衛生部門。
他說：“而且，真正出現對人或環境產生威脅的情況是很罕見的”。
除了向縣衛生部門發出警報外，USAMRIID官員還按照協議與縣行政部門，馬里蘭州衛生部和馬里蘭州公共衛生實驗室進行了聯繫，縣行政人員Jan Gardner在語音郵件回覆中說。
她在語音郵件中說：“當然，我所有優先考慮的事情都與公共衛生和福利有關。” “因此，我想確保對我們社區的公共健康和福利或在Fort Detrick工作的工人（通常是我們社區的成員）沒有威脅。”
加德納說，更多具體問題應諮詢USAMRIID。
Effect of USAMRIID shutdown on research at Fort Detrick unclear
By Heather Mongilio [email protected] Aug 7, 2019 7
A decision by the Centers for Disease Control and Prevention to shut down a Fort Detrick military lab may affect research underway there.
At the time of a cease and desist letter from the CDC, the U.S. Army Medical Research Institute of Infectious Diseases was working on a multi-year project to develop antibody-based therapies for four lethal viruses.
The project is led by the Albert Einstein College of Medicine, under the Montefiore Medical Center, and was awarded $22 million in April, according to a press release. Mapp Biopharmaceutical Inc., the University of Texas at Austin and Adimab LLC are also partners.
The military lab has been offline since July when it received the CDC letter sent after a June inspection, according to previous News-Post reporting. The lab’s registration in the Federal Select Agent Program was also suspended.
It is unclear how the research shutdown in July will affect the project. USAMRIID is working to meet benchmarks set by the CDC and the Army so that it can begin research again, but it is unclear how long that will take.
The goal of the five-year project was to create treatments for Crimean-Congo hemorrhagic fever virus, Andes virus, Sin Nombre virus and Puumala virus, which do not have any approved vaccines or treatments. Crimean-Congo hemorrhagic fever virus falls under the U.S. Department of Health and Human Services’ select agents and toxins list.
No one at Albert Einstein College of Medicine was available to answer questions about USAMRIID’s research shutdown, a spokeswoman said in an email.
The Albert Einstein project was just one of the many projects scientists at USAMRIID were working on.
In March, USAMRIID announced that the Food and Drug Administration provided an agreement that would allow an animal model to help develop remdesivir, which is used to treat Ebola.
Remdesivir is developed by Gilead Sciences Inc., with assistance from USAMRIID and the CDC.
USAMRIID is also part of a $11.7 million project with Tasso Inc., Ceres Nanosciences and George Mason University to create a universal surveillance platform for infectious disease outbreaks, announced in September 2017.
Requests for comments to Gilead, Tasso and Ceres had not been returned as of 6 p.m. Wednesday. A spokeswoman for USAMRIID was still working to answer questions.
When they knew
The Frederick County Health Department was notified after the cease and desist letter, around mid-July, according to Randall Culpepper, director of HealthCare Connection and Preparedness at the Frederick County Health Department. The department will meet with USAMRIID officials again this week.
Whenever there is an issue or potential public health threat, USAMRIID informs the health department, he said.
“And it’s really rare that there is an actual threat, human or environmental threat,” he said.
In addition to alerting the county health department, USAMRIID officials contacted the county executive, the Maryland Department of Health and Maryland Public Health Laboratory, as per protocol, County Executive Jan Gardner said in a voice mail response for comment.
“Certainly, all my priority interest is related to public health and welfare,” she said in the voice mail. “So I wanted to make sure that there was no threat to public health and welfare in our community or to the workers that work at Fort Detrick, who are generally members of our community.”
Gardner said more specific questions should be referred to USAMRIID.
閱讀更多 地上殲八 的文章
